The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Letters

• Publication date

  2017-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2017.07.004PMID 28716524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Megakaryocytic Differentiation of K562 Cells Induced by PMA Reduced the Activity of Respiratory Chain Complex IV

  2014cited by this paper
• The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8

  2013influential reference
• Small proline‐rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage‐induced apoptosis

  2013cited by this paper
• The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1.

  2013cited by this paper
• Death by caspase dimerization.

  2012cited by this paper
• Assembling the building blocks: structure and function of inhibitor of apoptosis proteins

  2010cited by this paper
• The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and -7 via Unique Mechanisms at Distinct Steps in Their Processing*

  2009cited by this paper
• Inactivation of effector caspases through nondegradative polyubiquitylation.

  2008cited by this paper
• A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.

  2007cited by this paper
• Protein kinase C (PKC) family in cancer progression.

  2006cited by this paper
• Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine.

  2006cited by this paper
• Molecular mechanisms of caspase regulation during apoptosis

  2004cited by this paper
• Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells*

  2004cited by this paper
• Mechanism of XIAP-mediated inhibition of caspase-9.

  2003cited by this paper
• Protein kinase Cα (PKCα): Regulation and biological function

  2002cited by this paper
• Protein kinase C alpha (PKC alpha): regulation and biological function.

  2002cited by this paper
• Structural basis of caspase-7 inhibition by XIAP.

  2001cited by this paper
• Protein kinase C inhibitors as novel anticancer drugs

  2001cited by this paper
• Dimer formation drives the activation of the cell death protease caspase 9

  2001cited by this paper
• Structural basis for the inhibition of caspase-3 by XIAP.

  2001cited by this paper
• Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo

  2001cited by this paper
• Requirement for ERK Activation in Cisplatin-induced Apoptosis*

  2000cited by this paper
• MAPK/ERK signaling in activated T cells inhibits CD95/Fas‐mediated apoptosis downstream of DISC assembly

  2000cited by this paper
• Role of cytochrome c and dATP/ATP hydrolysis in Apaf‐1‐mediated caspase‐9 activation and apoptosis

  1999cited by this paper
• Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

  1999cited by this paper
• Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis

  1999cited by this paper
• Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

  1999cited by this paper
• Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.

  1998cited by this paper
• Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

  1997cited by this paper
• Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

  1996cited by this paper

• Structure and mechanism of the HECT ligase HECTD3.

  2026cites this paper
• Expression of HECTD3 in Epithelial Ovarian Cancer and Its Effect on Platinum Resistance

  2025cites this paper
• HECTD3 E3 ligase mediates ubiquitination of AKT-phosphorylated CMTM3 in HER2-overexpressed breast cancer cells.

  2025cites this paper
• Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis.

  2025cites this paper
• Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non‐Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning

  2025cites this paper
• Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas

  2024cites this paper
• Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells

  2024cites this paper
• Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells

  2023cites this paper
• HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC

  2022cites this paper
• The roles of ubiquitination‐mediated intrinsic apoptotic signalling in cancer therapy

  2022cites this paper
• HECTD3 enhances cell radiation resistance and migration by regulating LKB1 mediated ZEB1 in glioma

  2022cites this paper
• HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway

  2022cites this paper
• ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway

  2021cites this paper
• Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis

  2021cites this paper
• USP12 promotes breast cancer angiogenesis by maintaining midkine stability

  2021cites this paper
• Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells

  2021cites this paper
• Exploring the "other" subfamily of HECT E3-ligases for therapeutic intervention.

  2021cites this paper
• Constitutive activity of GPR26 regulated by ubiquitin‐dependent degradation and its antitumor role

  2021cites this paper
• HECT E3 ubiquitin ligases – emerging insights into their biological roles and disease relevance

  2020cites this paper
• The role of E3 ubiquitin ligase HECTD3 in cancer and beyond

  2019cites this paper
• Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation

  2019cites this paper
• C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.

  2018cites this paper
• Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.

  2017cites this paper